Cargando…
Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents
Mpox virus (formerly monkeypox virus [MPXV]) is a neglected zoonotic pathogen that caused a worldwide outbreak in May 2022. Given the lack of an established therapy, the development of an anti-MPXV strategy is of vital importance. To identify drug targets for the development of anti-MPXV agents, we...
Autores principales: | Hishiki, Takayuki, Morita, Takeshi, Akazawa, Daisuke, Ohashi, Hirofumi, Park, Eun-Sil, Kataoka, Michiyo, Mifune, Junki, Shionoya, Kaho, Tsuchimoto, Kana, Ojima, Shinjiro, Azam, Aa Haeruman, Nakajima, Shogo, Kawahara, Madoka, Yoshikawa, Tomoki, Shimojima, Masayuki, Kiga, Kotaro, Maeda, Ken, Suzuki, Tadaki, Ebihara, Hideki, Takahashi, Yoshimasa, Watashi, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434032/ https://www.ncbi.nlm.nih.gov/pubmed/37409948 http://dx.doi.org/10.1128/spectrum.00566-23 |
Ejemplares similares
-
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments
por: Akazawa, Daisuke, et al.
Publicado: (2023) -
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
por: Ohashi, Hirofumi, et al.
Publicado: (2022) -
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
por: Ohashi, Hirofumi, et al.
Publicado: (2021) -
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021) -
Bacteriophages as Solid Tumor Theragnostic Agents
por: Veeranarayanan, Srivani, et al.
Publicado: (2021)